PMA device
Legend Plus Family of Pacemakers
Medtronic, Inc. · Pulse Generator, Permanent, Implantable (NVZ, Class III) · First FDA decision May 12, 2006, newest May 13, 2011Bradycardia and heart blockHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
544
Naming "Legend Plus"
MAUDE reports
0
Brand "Legend Plus", since 2015
PubMed studies
5
Mentioning "Legend Plus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Legend Plus Family of Pacemakers
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- LEGEND PLUS FAMILY OF PACEMAKERSPMA supplement
P930022-S012 · Decided May 13, 2011 · 129 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- LEGEND PLUS FAMILY OF PACEMAKERSPMA supplement
P930022-S009 · Decided May 21, 2009 · 80 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- LEGEND PLUS FAMILY OF PACEMAKERSPMA supplement
P930022-S007 · Decided Nov 21, 2008 · 116 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Legend Plus", any status and sponsor, newest update first.
- Hyaluronic Acid Barrier in ParotidectomyNot yet recruiting
Milton S. Hershey Medical CenterAcademic, hospital or other
NCT07941011 · 20 participants (planned) · Start Jan 1, 2027 · Primary completion Jan 31, 2029
Device: Axoguard HA+ Nerve Protector · For: Parotidectomy, Patient-reported Outcomes; Parotid Cancer; Parotid Gland Tumor and 2 more
- Halova Vaginal Ovules Versus Vaginal Estriol for Genitourinary Symptoms in Postmenopausal WomenCompleted
Perfect Care DistributionNot on our public-company list
NCT07932990 · 252 participants · Start Mar 7, 2025 · Primary completion Apr 22, 2026
Device: Halova vaginal ovules · For: Genitourinary Syndrome of Menopause (GSM); Vaginal Dryness; Vulvo Vaginal Atrophy (VVA)
Sites: Arad, Romania
Fatih Sultan Mehmet Training and Research HospitalAcademic, hospital or other
NCT07487038 · 133 participants · Start Jan 1, 2023 · Primary completion Dec 31, 2025
Device: Intra-articular hyaluronic acid injection · For: Knee Osteoarthristis; Hyaluronic Acid
Sites: Ataşehir, Turkey (Türkiye)
541 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Legend Plus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NVZ
72,953 reports: 32,608 malfunction, 38,411 injury, 1,913 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Legend Plus"[tiab]. The summary above synthesizes these.
- Initial clinical experience with a new dual sensor SSIR pacemaker controlled by body activity and minute ventilation.
Alt E, Combs W, Fotuhi P, et al. · Pacing Clin Electrophysiol · 1995
- Dual sensor VVIR mode pacing: is it worth it?
Sulke N, Tan K, Kamalvand K, et al. · Pacing Clin Electrophysiol · 1996Clinical Trial, Randomized Controlled Trial
- [Metabolic parameters in the evaluation of frequency-adaptive sensors in pacemakers].
Pavlovik SU, Velimirovik D, Rebik P, et al. · Srp Arh Celok Lek · 2000English Abstract
- Multisensory principle of heart rate regulation.
Pavlovic SU · Med Sci Monit · 2000Comparative Study
- Evaluation of a new rate adaptive ventricular pacemaker controlled by double sensors.
Ovsyshcher I, Guldal M, Karaoguz R, et al. · Pacing Clin Electrophysiol · 1995
Other devices of this type
Also filed under product code NVZ.
- CareLink Instruments & DDMA, CareLink SmartSync Common ApplicationMedtronic, Inc. · PMA 2023
- Affinity/Integrity/Victory/Zephyr/Accent Family of PacemakersAbbott Medical · PMA 2016
- Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)Medtronic, Inc. · PMA 2017
- Various Families of PacemakersMedtronic, Inc. · PMA 2008
- Cadence Family of IcdsAbbott Medical · PMA 2012
- Medtronic CareLink Monitor, CardioSight ReaderMedtronic, Inc. · PMA 2019
- Advisa DR MRI SureScan Model A2DR01 IPG, Advisa SR MRI SureScan Model A3SR01 IPGMedtronic, Inc. · PMA 2022
- AdaptaMedtronic, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.